Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 196 AL 210

Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease

McLarnon JG.

Curr Alzheimer Res. 2019;16(11):1007-1017. doi: 10.2174/1567205016666191106095038.

Alzheimer's therapy development: A few points to consider

Sigurdsson EM.

Prog Mol Biol Transl Sci. 2019;168:205-217. doi: 10.1016/bs.pmbts.2019.06.001. Epub 2019 Jun 26.

Why delay in effective treatment for Alzheimer's disease and related conditions

Iqbal K, Liu F, Gong C, Dai C, Hu W.

Prog Mol Biol Transl Sci. 2019;168:243-256. doi: 10.1016/bs.pmbts.2019.08.002. Epub 2019 Aug 30.

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis

Lakey-Beitia J, Kumar D J, Hegde ML, Rao KS.

Int J Mol Sci. 2019 Nov 7;20(22):5553. doi: 10.3390/ijms20225553.

Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer's Disease

Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):771. doi: 10.2174/156720501609191029115310.

Metal ions and degenerative diseases

Quintanar L, Lim MH.

J Biol Inorg Chem. 2019 Dec;24(8):1137-1139. doi: 10.1007/s00775-019-01744-4.

Anthocyanins Potentially Contribute to Defense against Alzheimer's Disease

Afzal M, Redha A, AlHasan R.

Molecules. 2019 Nov 22;24(23):4255. doi: 10.3390/molecules24234255.

The use of Huperzia species for the treatment of Alzheimer's disease

Kim Thu D, Vui DT, Ngoc Huyen NT, Duyen DK, Thanh Tung B.

J Basic Clin Physiol Pharmacol. 2019 Nov 28;31(3):/j/jbcpp.2020.31.issue-3/jbcpp-2019-0159/jbcpp-2019-0159.xml. doi: 10.1515/jbcpp-2019-0159.

Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?

Ahn KC, Learman CR, Baker GB, Weaver CL, Chung PS, Kim HG, Song MS.

J Korean Med Sci. 2019 Dec 2;34(46):e297. doi: 10.3346/jkms.2019.34.e297.

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease

Jia L, Piña-Crespo J, Li Y.

Mol Brain. 2019 Dec 4;12(1):104. doi: 10.1186/s13041-019-0525-5.

Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer's disease

Wirths O, Zampar S.

Expert Opin Ther Targets. 2019 Dec;23(12):991-1004. doi: 10.1080/14728222.2019.1702972. Epub 2019 Dec 12.

β-amyloid and Oxidative Stress: Perspectives in Drug Development

Caruso G, Spampinato SF, Cardaci V, Caraci F, Sortino MA, Merlo S.

Curr Pharm Des. 2019;25(45):4771-4781. doi: 10.2174/1381612825666191209115431.

Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis

Teixeira JP, de Castro AA, Soares FV, da Cunha EFF, Ramalho TC.

Molecules. 2019 Dec 3;24(23):4410. doi: 10.3390/molecules24234410.

Role of Ceramidases in Sphingolipid Metabolism and Human Diseases

Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY.

Cells. 2019 Dec 4;8(12):1573. doi: 10.3390/cells8121573.

Rhinorrhea as a Result of Alzheimer's Disease Treatment: A Case Report

Bartlett D, Bear M.

Sr Care Pharm. 2019 Dec 1;34(10):669-673. doi: 10.4140/TCP.n.2019.669.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias